Please login to the form below
vaccines
This page shows the latest vaccines news and features for those working in and with pharma, biotech and healthcare.
Neoantigen player Achilles gets OK for first clinical trial
It’s operating in a busy field in immuno-oncology, with a clutch of companies focusing on neoantigens as a way to tackle cancer using drug, vaccine or cell therapy approaches.
Latest news
-
Industry pleads for compromise after Brexit defeat
The focus of pharmaceutical companies is on making sure that medicines and vaccines get to patients whatever the Brexit outcome,” added Thompson.
-
GSK upbeat on its return to oncology market
a ‘pure play’ pharma and vaccines company. ... Nevertheless, there is expected to be strong performances from its Shingrix vaccine and next-generation respiratory drug Ellipta, which have both been the focus of GSK’s new drive towards commercial
-
Moderna CEO makes case for firm’s lofty valuation
studies of candidates for respiratory syncytial virus (RSV) and a personalised cancer vaccine partnered with Merck &Co/MSD also at the planning stage. ... Other new studies coming up are phase 1 assessments of a triplet immuno-oncology drug (targeting
-
Pharma’s confidence in Brexit deal falls as vote looms
The latest guidance represents a ‘ramping up’ of no deal plans in seven key areas, namely: the supply of medicines and vaccines; the supply of medical devices and clinical consumables; the
-
GSK and Pfizer to create combined consumer health titan
Spin-out will allow GSK to focus on prescription drugs and vaccines. ... clear pathway forward for GSK to create a new global pharmaceuticals/vaccines company, with an R&D approach focused on science related to the immune system, use of genetics and
More from news
Approximately 93 fully matching, plus 975 partially matching documents found.
Latest Intelligence
-
The UK’s new five-year pricing agreement
This means that people across the UK should see better and faster access to the most effective new medicines and vaccines.”.
-
Innovation in merger control and the impact on the pharmaceutical sector
In the 1995 AMP/Wyeth merger, the parties divested one of the two development programmes for rotavirus vaccines to the Korean Green Cross. ... More than ten years later, GSK launched a rival vaccine, while the Korean Green Cross never did.
-
The handover: Pfizer reshapes itself for a new era
new therapies and vaccines.
-
In conversation with Pfizer’s Erik Nordkamp
The Life Sciences Industrial Strategy could increase the speed with which new medicines and vaccines are made available across the UK, if implemented in full and with the involvement and commitment
-
Biopharma's Future: Made in China
major scandal after ChangSheng Biotechnology was found to have falsified data and produced ineffective vaccines in the country, with another, the Wuhan Institute, found to have also produced substandard vaccines.
More from intelligence
Approximately 4 fully matching, plus 80 partially matching documents found.
Latest appointments
-
Bone Therapeutics strengthens board with new chairman
He has also been a member of the corporate executive team for GlaxoSmithKline and chief executive officer of GSK Biologicals (now GSK Vaccines).
-
McCann Health appoints Daniel Carucci as global medical director
Dr Carucci has over 25 years of experience in large-scale innovation programs, vaccine development, organisational leadership, and global public health, during which time he served as VP for global health
-
Professor Carole Longson moves from NICE to the ABPI
and the role our members play in developing new innovative medicines and vaccines.
-
Lilly bolsters its oncology team
Furthermore, she has been on the forefront of research in oncology vaccines, immuno-oncology and biosimilars, giving her the unique expertise that will be pivotal in helping us continue to develop
-
Relay Therapeutics appoints Sarah O’Brien as VP of HR
Prior to Sobi, O’Brien spent seven years working at Novartis for its vaccines arm and then with the Novartis Institute for Biomedical Research (NIBR), where she worked closely with the
More from appointments
Approximately 5 fully matching, plus 61 partially matching documents found.
Latest from PMHub
-
Cell Culture Incubator Market Global Industry Analysis and Forecast Till 2027
Cell Culture Incubator Market: Drivers and Restraints. Factors such as the increasing regulatory approvals for cell culture-based vaccines, increasing incidence of chronic diseases, growing demand for monoclonal antibodies, funding for ... Favorable
-
Dengue Vaccine Market To Increase at Steady Growth Rate of US$ 1,250.6 Mn By 2027
The market, at present, will witness sales of the sole of vaccine, Dengvaxia, developed by Sanofi. ... Live attenuated vaccines are being developed &produced economically, thereby comforting vaccine makers as well as patients.
-
Veterinary Vaccines Market Explores New Growth Opportunities By 2016 - 2026
Request to View Sample of Research Report @ . Highest Veterinary Vaccine Sales recorded in Jordan. A regional analysis of the veterinary vaccines market in the Middle East identified Jordan as the most ... And, these vaccines are likely to enter the
-
Companion Animal Vaccines Market Expected To Observer Major Growth By 2026
Established Companion Animal Vaccine Manufacturers are eyeing Inorganic Growth Opportunities in Latin America and Africa. ... The FMI study covers the entire macroeconomic and microeconomic spectrum influencing the companion animal vaccines market.
-
Auto-Injectors Market to Witness Steady Growth During the Forecast Period 2016-2026
Majority pharmaceutical companies are shifting from small molecules to biologics and vaccines, driven by increased efficacy and immunogenic of large molecules.
More from PMHub
Approximately 6 fully matching, plus 23 partially matching documents found.
Featured jobs
- Technical Manager – Developer and Commercial Excellence, Healthc...
-
Excellent package
-
Senior Medical Writer
-
Salary TBC
- Editorial Assistant Medical Education Agency
-
£25, 000 - £26, 000
-
Account Director, Medical Education
-
Salary TBC
-
Account Manager / Account Director
-
Competative
- Engagement Expert, Healthcare Brand Communications, London
-
Excellent package
- Senior Account Manager, Rare Diseases – Medical Communications, ...
-
Excellent package
-
Medical Writer
-
Salary TBC
- Account Manager / Senior Account Manager
-
35, 000-40, 000
- Senior Account Director development role to Business Director, H...
-
Excellent package
- Global Business Development Director – Health Education
-
excellent commission
-
Associate Director
-
£75, 000-90, 000
Subscribe to our email news alerts
- Europe closer to biosimilar rule change, despite fierce resistance from pharma
- FDA expecting boom in cell and gene therapies
- Moving annual total (MAT)
- AZ’s Sean Bohen to exit after business overhaul; report
- FDA moves into crisis mode as shutdown drags on
- Lucid Group prepare for a transformative year with the appointment of a new Director of Corporate Development
PMHub
Digitas Health
Digitas Health is the only digital-at-the-core brand agency designed to connect today's healthcare brands with today's healthcare consumers and professionals....
Latest intelligence
- NHS regional footprints
- What to expect from 2019...
- Not another weight-loss ad
- Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...
- China’s clinical trial shake-up
- As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...
Quick links
Infographics
